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Abstract 
Purpose: To study the effects of Salvia miltiorrhiza Bge. extract (SMBE) on thrombosis in rats.   
Methods: SMBE was obtained in water at 60 oC in an oven and then freeze-drying. Rats were divided 
into 6 groups of ten rats each: normal group, control group, reference group (aspirin 5 mg/kg) as well as 
three groups of SMBE groups (25, 50 and 100 mg/kg doses). Treatments were given orally once daily 
for 14 days. Common carotid artery FeCl3-induced thrombus and inferior vena cava thrombosis 
occlusion time, plasma concentrations of thromboxane B2 (TXB2) and 6-keto-prostaglandine F1α (6-
keto-PGF1α) were measured in the rats. 
Results: Compared with control group, all doses of SMBE significantly and dose-dependently 
prolonged thrombosis occlusion time, reduced the weight of thrombus and increased the inhibition rate 
of thrombus (p < 0.01). Plasma TXB2 concentration of all SMBE groups decreased dose-dependently (p 
< 0.05) while that of 6-keto-PGF1α increased with decrease in extract dose (p < 0.05). There was 
association between 6-keto-PGF1α/TXB2 and arterial or venous thrombus weight for all treatments, and 
also with occlusion time for SMBE treatment, but not for aspirin. 
Conclusion: The results demonstrate the anti-thrombosis effect of SMBE in rats. This finding suggests 
that the plant is a potential therapy for thrombosis.  
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Danshen, the dry root and rhizome of Salvia 
miltiorrhiza Bge (Labiatae), is one of the popular 
herbs used in China and the neighboring 
countries. This herb is widely applied in 
traditional Chinese medicine for promotion of 
blood flow to overcome blood stasis and to 
resolve abscesses [1]. Moreover, the extracts 
from the roots of this plant effectively prevented 
development of bone loss and increase blood 
estrogen level in a rat model of osteoporosis [2]. 
Several preparations that contain its major 
bioactive ingredients are also effective for 
microcirculation and coronary vasodilation and 
prevent inflammatory factors, and are therefore 
used against hypertension and inflammatory 
diseases [3]. Furthermore, a purified extract of 
this plant containing its major constituents, 
cryptotanshinone, tanshinone I, and tanshinone 
IIA can protect against liver toxicity in vivo and in 
vitro [4]. It has been reported that 
cryptotanshinone, tanshinones I and IIA, and 
salvianolic acid B are the major bioactive 
hydrophilic constituents present in roots of Salvia 
miltiorrhiza Bge. collected from different areas of 
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China. In addition, Salvia Miltiorrhiza Bge. has 
been shown to possess unique efficacy in 
treating thromboangiitis obliterans [5].  
 
Sequel to the use of Salvia Miltiorrhiza Bge. in 
the prevention of cardiovascular disease [6], this 
study was performed to study the effect of SMBE 






Root of Salvia miltiorrhiza Bge. were collected 
from Shiyan City, Hubei Province in China in May 
2015. Taxonomic identification of the plant was 
performed by Professor Ping He of College of 
Pharmacy of Southern Medical University in 
China. A voucher specimen of herbarium (no. 
SMBE 20150504) was deposited in the College 
of Pharmacy, Southern Medical University, China 
for future reference. SMBE was obtained by 
steeping the dried Salvia miltiorrhiza Bge. in 
water at 60 oC three times, each for 1 h in an 
oven and then it was freeze-dried. One gram 
powder was equivalent to about 1.5 g crude 
samples. The yield was 66.67 %. 
 
Other drugs and reagents were aspirin (Sigma 
Co, USA), 6-keto-PGF 1α and TXB2 RIA kits 




SD Wistar hypertensive rats weighing 200 - 250 
g were provided by Experimental Animal Center 
of Guangdong Province (certificate no. SYXK 
2002-0006). The animals had free access to food 
and water, and were allowed to acclimatize for at 
least one week before use. The rat experiment 
was approved by Animal Care and Use 
Committee of Southern Medical University 
(approval ref no. 20150904) and was carried out 
in compliance with Directive 2010/63/EU on the 
handling of animals used for scientific purposes 
[8]. The rats were randomly divided into 6 groups 
of ten rats: normal group, control group, 
reference group (aspirin 5 mg/kg) as well as 
SMBE groups, namely, 25, 50 and 100 mg/kg 
doses. Treatments were given orally once daily 
for 14 days. 
 
Studies on common carotid artery 
thrombosis  
 
After the last administration, rats were 
anesthetized with 3 % barbital sodium (0.5 
ml/100 g i.p.). Under sterile conditions of class 
SPF animal room, the rats were fixed on 
anatomical plane in supine position, the hairs on 
the throat were sheared and the skin was 
disinfected with iodine. An incision was made of 
about 3 cm in the midline on the throat [9-12]. 
The left common carotid artery was isolated for 2 
cm in length carefully and a plastic sheet (3 cm × 
1.5 cm) was placed under the vessel to separate 
it from the surrounding tissue. The surface of 
carotid artery was covered with a piece of filter 
paper (1 cm × 1 cm) saturated with 40 % FeCl3 
solution (normal saline in sham group)[13,14]. 
The temperature of the distal arterial surface was 
monitored by a thermometer. The time from 
when the filter paper was placed to a sudden 
drop in the temperature was recorded as 
thrombosis occlusion time (OT). An injured 
carotid artery segment (0.6 cm) was then cut off 
and placed on the filter paper to dry and was 
then weighed. The rate of thrombosis inhibition 
(Ti) was computed as in Eq 1. 
 
Ti (%) = {(A - A1)/A}100 ………………….. (1) 
 
where A and A1 are the wet weight of the 
thrombus in the control l group and aspirin- or 
extract-treated groups, respectively. 
 
Studies on inferior vena cava thrombosis 
 
Under sterile conditions of class SPF animal 
room, the rats were fixed on anatomical planes in 
supine position, the hairs of the abdomen were 
scraped off and the skin was disinfected with 
iodine and draped. An abdominal incision was 
made along the medio-ventral line. Inferior vena 
cava was isolated and ligated with silk thread 
below the left renal vein branch. The abdominal 
walls were subsequently closed. 4 h later the 
abdomen was reopened, the inferior vena cava 
was clamped about 2 cm below the ligature and 
other branches were ligated. The inferior cava 
vein was opened lengthwise, the thrombus was 
removed and placed on the filter paper to dry, 
then was weighed [15,16]. Thrombosis inhibition 
was calculated as in Eq 1 above. 
 
Measurement of plasma concentration of 6-
keto-PGF1α and TXB2  
 
One and half hours after surgery, the abdominal 
aorta was isolated and punctured for collecting 3 
mL blood. Plasma was separated and stored at -
20 oC. The plasma concentrations of 6-keto-
PGF1α and TXB22 were measured by 




Data are expressed as mean ± standard 
deviation (SD). Significant differences between 
the groups were analyzed using one-way 
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analysis of variance (ANOVA) followed by two-





FeCl3-induced common carotid artery 
thrombosis 
 
Compared with the control group, SMBE 
significantly and dose-dependently prolonged 
thrombosis occlusion time, reduced the weight of 
thrombus and increased inhibition rate (p < 0.01). 
Aspirin (5 mg/kg) had the same effect as SMBE 
(50 mg/kg) for inhibition of thrombus weight, but 
less effect on occlusion time (Table 1). 
 
Inferior vena cava thrombosis 
 
Compared with the control group, SMBE 
significantly and dose-dependently reduced the 
weight of thrombus, increasing inhibitory rate (P 
< 0.01). The effects of aspirin were similar to that 
of the medium dose of SMBE (Table 2). 
 
Plasma TXB2 and 6-keto-PGF1α 
 
Compared with the normal group, arterial plasma 
6-keto-PGF1α concentration was decreased (p < 
0.05) and TXB2 concentration was increased (p 
< 0.05) in the control group.  
 
Compared with the control group, the plasma 
TXB2 concentration of all SMBE groups was 
decreased dose-dependently (p < 0.05) while 
that of 6-keto-PGF1α was increased but with a 
reversed dose-dependence (p < 0.05).  
 
Aspirin inhibited the secretion of both 6-keto-
PGF1α and TXB2 significantly. 
 
 
      Table 1: Effect of SMBE on FeCl3-induced common carotid artery thrombosis in rats 
 
Group N Dose (mg/kg) OT (min) Weight of thrombus (mg) Inhibition rate (%) 
Control 10 — 8.53±1.4 16.8±0.6  
Aspirin 10 5 20.5±2.1* 6.6±1.3* 52.8 
SMBE-L 10 25 27.2±3.2* 9.8±1.4* 34.6* 
SMBE-M 10 50 34.1±5.2* 7.5±1.4* 55.3* 
SMBE-H 10 100 45.3±4.5*# 5.7±1.3*#  68.2*# 
OT = thrombosis occlusion time; SMBE–L: low-dose of SMBE, SMBE–M: middle- dose of SMBE, SMBE–H: high-
dose of SMBE (mean ± SD, n = 10). *p < 0.01 vs. control group; #p < 0.05 vs. aspirin group 
 
    Table 2: Effect of SMBE on inferior vena cava thrombosis in rats 
 
Group N Dose (mg/kg) Weight of thrombus (mg) Inhibition rate (%) 
Control 10 — 24.6±7.8  
Aspirin 10 5 6.3±1.7* 66.9* 
SMBE-L 10 25 13.7±4.9* 39.2* 
SMBE-M 10 50 7.6±2.2* 63.5* 
SMBE-H 10 100 5.8±1.5*# 67.4*# 
SMBE–L:low-dose of SMBE, SMBE–M: middle- dose of SMBE, SMBE–H: high-dose of SMBE. *P < 0.01 vs. 
control group; #p < 0.05 vs. (mean ± SD, n = 10) aspirin group 
 
           Table 3: Effect of SMBE on the plasma concentrations of 6-keto-PGF1α and TXB2 in rats  
 
Group N Dose (mg/kg) 6-Keto-PGF1α (pg/ml)  TXB2 (pg/ml) 
Control 10 — 568.32±305.12 238.17±103.43 
Aspirin 10 — 247.26±214.22 719.24±278.36 
SMBE-L 10 25 186.37±102.25* 91.24±35.17* 
SMBE-M 10 50 533.56±276.33* 431.18±218.32* 
SMBE-H 10 100 318.24±149.28* 211.53±128.26* 
SMBE–L: low-dose of SMBE, SMBE–M: middle- dose of SMBE, SMBE–H: high-dose of SMBE (mean ± SD, n = 




Many clinical studies showed that Danshen and 
its preparations are effective for the treatment of 
coronary artery diseases, angina pectoris, 
myocardial infarction, cerebrovascular diseases, 
various types of hepatitis and chronic renal 
failure [19]. Ligation of veins causes focal blood 
stasis, injury of vascular endothelial cell and 
hypoxia [20]. Danshen and its medicinal products 
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are widely used in Asian area for supporting 
cardiovascular function; evaluation of the active 
constituents in this herb is essential to ensure the 
efficiency of medication. Studies showed that this 
herb contains several pharmacologically active 
compounds, especially the diterpene diketones 
known as tanshinones. Due to injury of vascular 
endothelial cell, synthesis of PGI2 decrease and 
plasma TXA2 increased [21], further promoting 
platelet adhesion and aggregation and 
imbalance of TXA2/PGI2, which leads to 
vasoconstriction, platelet aggregation, and 
thrombosis [22]. The biological half-life of serum 
TXA2 is only 30 seconds, and TXA2 transformed 
to TXB2 quickly. Therefore, we measured TXB2 
in our experiment. 
 
Compared with the model group, SMBE dose-
dependently prolonged OT, reduced the weight 
of arterial and venous thrombosis. The extracts 
also decrease plasma TXB2 concentrations and 
increased 6-keto-PGF1α, thereby increasing the 
6-keto-PGF1α to TXB2 ratio. The anti-thrombotic 
effect of SMBE was probably mediated by 
regulating the prostacyclin/thromboxane balance 
and the ratio, resulting in a ratio that was 
dependently related to thrombus weight. Arterial 
occlusion time was linearly related to the ratio for 
control, aspirin and SMBE -H (r2 = 0.999) but 
SMBE -M and SMBE -L appear not to lie on the 
same line. Furthermore, SMBE perhaps had 
some additional effect that prolongs occlusion 
time beyond what would be expected from the 
effect on cycloxygenase, or more generally on 
the synthesis of thromboxane and PGI2, 
especially for the lower SMBE doses. It is 
uncertain whether this is related to a differential 
effect on platelets rather than to actual 





The findings of this study indicate the anti-
thrombosis effect of SMBE in Further studies are, 
however, required to ascertain its therapeutic 
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